TTBIO Corp

TTBIO Corp's capital structure shows a debt-to-equity ratio of 0.49, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.37, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's operating cash flow is negative at -41,010,000 TWD, and free cash flow is only 2,080,000 TWD, which may limit its ability to fund operations and growth without external financing. Profitability metrics for TTBIO Corp are weak, with a return on equity of -5.96% and a return on assets of -3.42%. These figures indicate that the company is not generating returns that meet the cost of equity or assets, which is below the industry median for Medical Equipment, Supplies & Distribution. The company's operating income is negative at -21,231,000 TWD, and net income is also negative at -21,300,000 TWD, reflecting poor operational performance. The company's revenue is primarily concentrated in the domestic market, with limited information on geographic diversification. The lack of detailed segment data makes it difficult to assess the contribution of different regions or product lines to overall revenue. However, the company's distribution strategy includes both domestic and overseas markets, which may provide some level of diversification. TTBIO Corp's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year. The company's revenue history shows a total of 398,880,000 TWD in the latest period, but without prior year data, it is challenging to determine the growth rate. The company's capital expenditure of -6,647,000 TWD suggests some investment in infrastructure, but the negative value indicates a reduction in capital spending. Risk factors for TTBIO Corp include a medium liquidity risk due to negative operating cash flow and a low dilution risk. The company's key flags indicate that net cash is negative after subtracting total debt, which could lead to financial stress if not managed properly. The company's dilution potential is low, but the negative net income and operating cash flow may necessitate additional financing, which could lead to dilution in the future. Recent events for TTBIO Corp include the latest financial filing, which shows a negative net income and operating income. The company's financial performance has been impacted by a decline in profitability, as indicated by the negative return on equity and assets. The company's liquidity position is also a concern, with a negative operating cash flow and limited free cash flow. These factors may affect the company's ability to meet its financial obligations and invest in growth opportunities.